論文

• Hiroshi Nakagawa, Yasumasa Joti, Akio Kitao, Osamu Yamamuro, Mikio Kataoka. Universality and Structural Implications of the Boson Peak in Proteins, Biophysical Journal, 117, 2, 229-238, July 2019.  公式リンク  
  
• Hiroshi Nakagawa, Hasumi, K., Takami, M., Aida-Hyugaji, S., Woo, J. T., Kazuo Nagai, Toshihisa Ishikawa, Masaaki Wachi. Identification of two biologically crucial hydroxyl groups of (-)-epigallocatechin gallate in osteoclast culture, Biochem. Pharmacol., Vol. 73, No. 1, pp. 34-43, Jan. 2007.
• Tamura, A., Wakabayashi, K., Onishi, Y., Nakagawa, H., Tsuji, M., Matsuda, Y., Ishikawa, T.. Genetic Polymorphisms of Human ABC Transporter ABCG2: Development of the Standard Method for Functional Validation of SNPs by using the Flp Recombinase System., J. Exp. Ther. Oncol., Vol. 6, pp. 1-11, 2006.
• 田村藍, 大西裕子, 渡邉正人, 齊藤光, 中川大, 蒲池利章, 大倉一郎, 石川智久.. ヒトABCトランスポーターABCG2の遺伝子多型とポルフィリン症のリスク., Porphyrins, Vol. 15, pp. 21-22, 2006.
• Ishikawa, T., Ikegami, Y., Sano, K., Nakagawa, H., Sawada, S.. Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells., Curr. Pharm. Des., Vol. 12, pp. 313-325, 2006.
• Nakagawa, H., Saito, H., Ikegami, Y., Aida-Hyugaji, S., Sawada, S., Ishikawa, T.. Molecular Modeling of New Camptothecin Analogues to Circumvent ABCG2-mediated Drug Resistance in Cancer., Cancer Lett., Vol. 234, pp. 81-89, 2006.
• Saito, H., Hirano, H., Nakagawa, H., Fukami, T., Oosumi, K., Murakami, K., Kimura, H., Kouchi, T., Konomi, M., Tao, E., Tsujikawa, N., Tarui, S., Nagakura, M., Osumi, M., Ishikawa, T.. A New Strategy of High-Speed Screening and Quantitative SAR Analysis To Evaluate Human ABC Transporter ABCG2-Drug Interactions., J. Pharmacol. Exp. Ther., Vol. 317, pp. 1114-1124, 2006.
• Tamura, A., Watanabe, M., Saito, H., Nakagawa, H., Kamachi, T., Okura, I., Ishikawa, T.. Functional Validation of The Genetic Polymorphisms of Human ABC Transporter ABCG2: Identification of Alleles That Are Defective in Porphyrin Transport., Mol. Pharmacol., Vol. 70, pp. 287-296, 2006.
• Hirano, H., Kurata, A., Onishi, Y., Sakurai, A., Saito, H., Nakagawa, H., Nagakura, M., Tarui, S., Kanamori, Y., Kitajima, M., Ishikawa, Y.. High-Speed Screening and QSAR Analysis of Human ATP-Binding Cassette Transporter ABCB11 (Bile Salt Export Pump) To Predict Drug-induced Intrahepatic Cholestasis., Mol. Pharmaceutics, Vol. 3, pp. 252-265, 2006.
• Wakabayashi, K., Nakagawa, H., Adachi, T., Kii, I., Kobatake, E., Kudo, A., Ishikawa, T.. Cysteine-603 is a critical amino acid forhomodimer formation of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system., J. Exp. Ther. Oncol., Vol. 5, pp. 205-222, 2006.
• Shirasaka Y, Onishi Y, Sakurai A, Nakagawa H, Ishikawa T, Yamashita S.. Evaluation of Human P-Glycoprotein (MDR1/ABCB1) ATPase Activity Assay Method by Comparing with in Vitro Transport Measurements: Michaelis-Menten Kinetic Analysis to Estimate the Affinity of P-Glycoprotein to Drugs., Biol. Pharm. Bull., Vol. 29, pp. 2465-2471, 2006.
• Takahashi, T., Nakai, K., Doi, T., Yasunaga, M., Nakagawa, H., Ishikawa, T.. Synthesis and Evaluation of 3D Templates Based on a Taxane Skeleton to Circumvent P-glycoprotein-associated Multidrug Resistance of Cancer., Bioorg. Med. Chem. Lett., Vol. 15, pp. 2601-2605, 2005.
• Ishikawa, T., Tamura, A., Saito, H., Wakabayashi, K., Nakagawa, H.. Pharmacogenomics of the Human ABC Transporter ABCG2: From Functional Evaluation to Drug Molecular Design., Naturwissenschaften, Vol. 14, pp. 1-13, 2005.
• HIROSHI NAKAGAWA. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NFkappaB ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha)., Biochem Pharmacol., Vol. 69, No. 1, pp. 87-95, 2005.
• Nakagawa, H., Hasumi, K., Woo, J.-T., Nagai, K., Wachi, M.. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate, Carcinogenesis, Vol. 25, No. 9, pp. 1567-1574, Sept. 2004.
• HIROSHI NAKAGAWA. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate., Carcinogenesis, Vol. 25, No. 9, pp. 1567-1574, 2004.
• HIROSHI NAKAGAWA. Quercetin suppresses bone resorption by inhibiting differentiation and activation of osteoclasts., Biological Pharm. Bull., Vol. 27, No. 4, pp. 504-509, 2004.
• HIROSHI NAKAGAWA. Destruxins, cyclodepsipeptides, block the formation of actin rings, and prominent clear zones and ruffled borders in osteoclasts., Bone, Vol. 33, pp. 443-455, 2003.
• HIROSHI NAKAGAWA. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death., Biochem. Biophys. Res. Commun., Vol. 292, pp. 94-101, 2002.

著書

• 中川大, 永井和夫. 茶の効能と応用開発・破骨細胞の機能を調節する緑茶成分EGCG., シーエムシー出版, pp. 196-204, 2006.
• 石川智久, 櫻井亜季, 大西裕子, 中川大. バイオインダストリー・癌の薬剤耐性機構解明から薬物トランスポーター遺伝子多型の臨床診断へ., シーエムシー出版, Vol. 22, No. 3, pp. 11-16, 2005.

特許など

• 石川智久, 中川大, 渡邊　正人, 齊藤　光. ABCタンパク質が輸送する基質のスクリーニング方法、及びABCタンパク質の輸送活性の測定法. 特許. 公開. 国立大学法人東京工業大学. 2005/12/07. 特願2005-353801. 2007/06/21. 特開2007-151493. 2007.

学位論文

• 破骨細胞による骨吸収を抑制する低分子生理活性物質デストラキシン及びカテキンの骨吸収抑制機構に関する研究,  本文,  Doctor of Engineering,  Tokyo Institute of Technology,  2004/--/--, 

[ BibTeX 形式で保存 ]    [ 論文・著書をCSV形式で保存 ]    [ 特許をCSV形式で保存 ]